Ardelyx

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell Ardelyx and other ETFs, options, and stocks.

About ARDX

Ardelyx, Inc. is a commercial-stage biopharmaceutical company focused on the development and commercialization of innovative medicines that meet significant unmet medical needs. Its products include IBSRELA and XPHOZAH. 

CEO
Michael G. Raab
CEOMichael G. Raab
Employees
489
Employees489
Headquarters
Waltham, Massachusetts
HeadquartersWaltham, Massachusetts
Founded
2007
Founded2007
Employees
489
Employees489

ARDX Key Statistics

Market cap
1.30B
Market cap1.30B
Price-Earnings ratio
-22.12
Price-Earnings ratio-22.12
Dividend yield
Dividend yield
Average volume
6.51M
Average volume6.51M
High today
$5.31
High today$5.31
Low today
$5.14
Low today$5.14
Open price
$5.19
Open price$5.19
Volume
3.21M
Volume3.21M
52 Week high
$8.40
52 Week high$8.40
52 Week low
$4.08
52 Week low$4.08

Stock Snapshot

The current Ardelyx(ARDX) stock price is $5.28, with a market capitalization of 1.3B. The stock trades at a price-to-earnings (P/E) ratio of -22.12.

On 2026-07-05, Ardelyx(ARDX) stock traded between a low of $5.14 and a high of $5.31. Shares are currently priced at $5.28, which is +2.7% above the low and -0.6% below the high.

Ardelyx(ARDX) shares are trading with a volume of 3.21M, against a daily average of 6.51M.

During the past year, Ardelyx(ARDX) stock moved between $4.08 at its lowest and $8.40 at its peak.

During the past year, Ardelyx(ARDX) stock moved between $4.08 at its lowest and $8.40 at its peak.

ARDX News

TipRanks 2d
Ardelyx Secures New $50 Million Term F Loan

Unlock powerful investing tools and data-driven insights with TipRanks Premium for more confident investment decisions. Discover top stock picks and new invest...

Simply Wall St 4d
Ardelyx Faces New Medicare Rules For Xphozah After Court Ruling

U.S. federal appellate court rules that Ardelyx’s Xphozah will be included in Medicare’s ESRD bundled payment system, ending separate reimbursement. The decisi...

Ardelyx Faces New Medicare Rules For Xphozah After Court Ruling

Analyst ratings

100%

of 11 ratings
Buy
100%
Hold
0%
Sell
0%

People also own

Based on the portfolios of people who own ARDX. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.